What does Diagnamed Holdings Corp. do?

Diagnamed Holdings Corp. (DMED.CN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is DMED.CN's market cap?

Diagnamed Holdings Corp. (DMED.CN) has a market capitalization of approximately $5.5 million, as of August 28, 2026, based on the most recent share price and shares outstanding.

Does DMED.CN pay a dividend?

No — Diagnamed Holdings Corp. (DMED.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is DMED.CN profitable?

Diagnamed Holdings Corp. (DMED.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

DMED.CN

Diagnamed Holdings Corp.

CNQ·Biotechnology · Healthcare

C$0.06C$0.01+9.09%

Market capC$5.51M·Aug 28 1:55 PM UTC

Price Chart

C$0.06+C$0.01 (+9.09%)today

+0.00%CAGR +0.00%

Select date range

FromTo

Nov 8, 2022Nov 8, 2022 → Aug 28, 2026· 3.8 yrsAug 28, 2026

Key Metrics

DMED.CN does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateDec 30

Reported vs EstimateC$0.00

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$0.00

Net Income−C$1.85M

Net Margin—

Operating Cash Flow−C$582.73K

Capital ExpendituresC$3.00

Free Cash Flow−C$582.73K

Return on Equity—

Return on Invested Capital652.7%

Net CashC$293.76K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for DMED.CN and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how DMED.CN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DMED.CN and 80,000+ other tickers.

About Diagnamed Holdings Corp.

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.

CEO: John Ioannis Karagiannidis
Sector: Healthcare
Industry: Biotechnology
Exchange: CNQ
Employees: 5
Website: www.diagnamed.com

Peers

AI/ML Innovations Inc.

Cap

C$11.4M

BIOV.CN

BioVaxys Technology Corp.

Cap

C$2.0M

Latest News

News Tab

Black Pine Resources Announces Closing of Qualifying Transaction
Vancouver, British Columbia--(Newsfile Corp. - August 7, 2026) - Black Pine Resources Corp. (formerly Anquiro Ventures Ltd.) (the "Company") is
feeds.newsfilecorp.comAug 7, 2026 · 9:11 PM

Frequently Asked Questions About DMED.CN

What does Diagnamed Holdings Corp. do?: Diagnamed Holdings Corp. (DMED.CN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is DMED.CN's market cap?: Diagnamed Holdings Corp. (DMED.CN) has a market capitalization of approximately $5.5 million, as of August 28, 2026, based on the most recent share price and shares outstanding.
Does DMED.CN pay a dividend?: No — Diagnamed Holdings Corp. (DMED.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is DMED.CN profitable?: Diagnamed Holdings Corp. (DMED.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

Diagnamed Holdings Corp.

Frequently Asked Questions About DMED.CN

Diagnamed Holdings Corp.

Black Pine Resources Announces Closing of Qualifying Transaction

Frequently Asked Questions About DMED.CN

Black Pine Resources Announces Closing of Qualifying Transaction